EVAR 2 very long-term results prompt a call for shared decision-making in frail patients
cxsymposium2019-09-09T09:59:22+01:00A “podium first” presentation of very long-term follow-up data from the EVAR 2 trials suggests that endovascular aneurysm repair (EVAR) fails to improve all-cause mortality, but reduces aneurysm-related mortality compared to no treatment in abdominal aortic aneurysm patients who are physically ineligible for open repair. The data […]